X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5145) 5145
Publication (428) 428
Newspaper Article (71) 71
Book Review (69) 69
Book Chapter (41) 41
Newsletter (32) 32
Book / eBook (19) 19
Magazine Article (16) 16
Conference Proceeding (12) 12
Dissertation (5) 5
Trade Publication Article (4) 4
Reference (3) 3
Data Set (1) 1
Journal / eJournal (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3900) 3900
index medicus (2704) 2704
male (2352) 2352
female (2203) 2203
middle aged (2008) 2008
gastroenterology & hepatology (1851) 1851
aged (1692) 1692
gastroesophageal reflux (1664) 1664
surgery (1506) 1506
adult (1471) 1471
adenocarcinoma (1413) 1413
cancer (1318) 1318
oncology (1308) 1308
gastroesophageal junction (1229) 1229
esophageal cancer (826) 826
medicine & public health (816) 816
esophagus (776) 776
esophageal neoplasms - pathology (748) 748
gastroesophageal-reflux disease (745) 745
treatment outcome (739) 739
risk factors (728) 728
barretts-esophagus (692) 692
esophagogastric junction (691) 691
aged, 80 and over (678) 678
barrett's esophagus (660) 660
chemotherapy (648) 648
adenocarcinoma - pathology (601) 601
gastroesophageal reflux disease (582) 582
endoscopy (580) 580
care and treatment (579) 579
gastroenterology (562) 562
prevalence (544) 544
prognosis (521) 521
gastric cancer (517) 517
barrett esophagus - pathology (513) 513
retrospective studies (513) 513
diagnosis (512) 512
analysis (505) 505
stomach neoplasms - pathology (496) 496
carcinoma (483) 483
gastroesophageal reflux - complications (467) 467
gastroesophageal-reflux (456) 456
research (446) 446
stomach cancer (439) 439
prospective studies (421) 421
esophageal neoplasms - surgery (415) 415
health aspects (403) 403
abridged index medicus (395) 395
follow-up studies (393) 393
neoplasm staging (392) 392
gastric cardia (390) 390
intestinal metaplasia (381) 381
squamous-cell carcinoma (364) 364
disease (358) 358
esophagus - pathology (358) 358
esophagogastric junction - pathology (352) 352
biopsy (349) 349
gastroesophageal reflux - diagnosis (336) 336
stomach neoplasms - drug therapy (331) 331
adenocarcinoma - surgery (310) 310
patients (310) 310
therapy (310) 310
esophageal adenocarcinoma (307) 307
esophagoscopy (306) 306
animals (304) 304
gastroesophageal reflux - surgery (304) 304
metaplasia (298) 298
obesity (298) 298
survival (298) 298
gastroesophageal reflux - pathology (293) 293
dysplasia (286) 286
gastroesophageal reflux - physiopathology (285) 285
esophageal neoplasms - therapy (283) 283
abdominal surgery (280) 280
esophageal neoplasms - epidemiology (280) 280
esophageal neoplasms - etiology (278) 278
gastroenterology and hepatology (277) 277
hepatology (276) 276
esophagitis (274) 274
risk (270) 270
esophageal neoplasms - mortality (269) 269
antineoplastic combined chemotherapy protocols - therapeutic use (268) 268
studies (268) 268
gerd (267) 267
high-grade dysplasia (265) 265
laparoscopy (262) 262
esophagectomy (259) 259
proton pump inhibitors (259) 259
epidemiology (258) 258
stomach neoplasms - surgery (254) 254
risk-factors (253) 253
adenocarcinoma - epidemiology (252) 252
symptoms (252) 252
survival rate (251) 251
adolescent (250) 250
helicobacter-pylori infection (249) 249
pathology (247) 247
esophageal neoplasms - drug therapy (244) 244
immunohistochemistry (240) 240
incidence (240) 240
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5237) 5237
German (50) 50
Japanese (36) 36
French (26) 26
Spanish (11) 11
Chinese (3) 3
Korean (3) 3
Russian (2) 2
Serbian (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JNCCN Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 02/2015, Volume 13, Issue 2, pp. 194 - 227
Journal Article
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, ISSN 1540-1405, 07/2019, Volume 17, Issue 7, pp. 855 - 883
Esophageal cancer is the sixth leading cause of cancer-related deaths worldwide. Squamous cell carcinoma is the most common histology in Eastern Europe and... 
PHASE-II TRIAL | COMBINED-MODALITY THERAPY | GASTROESOPHAGEAL JUNCTION | ONCOLOGY | DOCETAXEL PLUS CISPLATIN | ADVANCED GASTRIC-CANCER | SQUAMOUS-CELL CARCINOMA | RANDOMIZED-TRIAL | OPEN-LABEL | QUALITY-OF-LIFE | 1ST-LINE THERAPY
Journal Article
Journal of Gastric Cancer, ISSN 2093-582X, 09/2018, Volume 18, Issue 3, pp. 209 - 217
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 4/2014, Volume 73, Issue 4, pp. 737 - 747
The aim of this study was to characterize trastuzumab population pharmacokinetics (PKs) in patients with human epidermal growth factor receptor 2-positive... 
Population pharmacokinetics | Gastroesophageal junction cancer | Medicine & Public Health | Exposure–response | Oncology | Cancer Research | Pharmacology/Toxicology | Gastric cancer | Trastuzumab | Exposure-response | SURVIVAL | EGF | RECEPTOR | HER-2 | AMPLIFICATION | GENE | ONCOLOGY | PHARMACOLOGY & PHARMACY | rastuzumab | Receptor, ErbB-2 - genetics | Capecitabine | Esophageal Neoplasms - blood | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Receptor, ErbB-2 - metabolism | Stomach Neoplasms - metabolism | Male | Stomach Neoplasms - pathology | Cisplatin - administration & dosage | Esophageal Neoplasms - pathology | Young Adult | Antibodies, Monoclonal, Humanized - administration & dosage | Fluorouracil - administration & dosage | Antibodies, Monoclonal, Humanized - pharmacokinetics | Antibodies, Monoclonal, Humanized - blood | Esophageal Neoplasms - metabolism | Aged, 80 and over | Adult | Female | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Esophagogastric Junction - metabolism | Esophagogastric Junction - pathology | Stomach Neoplasms - drug therapy | Stomach Neoplasms - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged | Esophageal Neoplasms - drug therapy | Deoxycytidine - analogs & derivatives | Antimitotic agents | Care and treatment | Chemotherapy | Epidermal growth factor | Analysis | Antineoplastic agents | Cancer
Journal Article
CIRUGIA ESPANOLA, ISSN 0009-739X, 10/2019, Volume 97, Issue 8, pp. 459 - 464
Adenocarcinomas of the gastroesophageal junction represent 27% of all gastric tumors. n recent years, it has been classified as an entity of its own, with... 
SURGERY | PERIOPERATIVE CHEMOTHERAPY | Gastroesophageal junction cancer | ADENOCARCINOMA | Adjuvant treatment | CURATIVE RESECTION | OPEN-LABEL | Neoadjuvant treatment | PHASE-III TRIAL | Perioperative treatment | ADJUVANT CHEMORADIOTHERAPY | ADVANCED GASTRIC-CANCER | NEOADJUVANT CHEMORADIOTHERAPY | DOUBLE-BLIND | ESOPHAGEAL CANCER | Gastric cancer
Journal Article
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, ISSN 1436-3291, 01/2020, Volume 23, Issue 1, pp. 133 - 141
There are few third-line or later (3L+) treatment options for advanced/metastatic (adv/met) gastric cancer/gastroesophageal junction cancers (GC/GEJC). 3L+... 
Gastroesophageal junction cancer | Original | Gastric cancer | Nivolumab
Journal Article
Expert Opinion on Biological Therapy, ISSN 1471-2598, 11/2019, Volume 19, Issue 11, pp. 1135 - 1141
Introduction: Gastric cancer remains one of the most lethal malignancy, accounting for an estimated 783,000 deaths worldwide in 2018. Although there are... 
targeted therapy | VEGFR-2 inhibitors | Ramucirumab | gastric cancer | gastroesophageal adenocarcinoma
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 09/2018, Volume 100, p. 17
Introduction IMAB362 (Zolbetuximab) is a chimeric monoclonal antibody that binds to Claudin-18.2, a target antigen specific to cancer cells. In vitro, IMAB362... 
Gastroesophageal reflux | Evaluation | Intravenous administration | Toxicity | Cytotoxicity | Radioactive half-life | Pharmacology | Patients | Esophagus | Anticancer properties | Studies | Infusion | Immunogenicity | Cell death | Safety engineering | Monoclonal antibodies | Solid tumors | Cancer
Journal Article
Journal Article